|
|
||||||||
J Thorac Cardiovasc Surg 2004;128:92-97
© 2004 The American Association for Thoracic Surgery
Cardiopulmonary support and physiology |
a Clinic for Cardiovascular Surgery, University Hospital Zürich, Zürich, Switzerland
b Institute of Clinical Chemistry, University Hospital Zürich, Zürich, Switzerland
Received for publication October 15, 2003; revisions received February 12, 2004; accepted for publication February 27, 2004.
* Address for reprints: Jürg Grünenfelder, MD, Clinic for Cardiovascular Surgery, University Hospital Zürich, Rämistrasse 100, 8091 Zürich, Switzerland
jurg.grunenfelder{at}chi.usz.ch
OBJECTIVE: Cardiopulmonary bypass induces a rise in cytokines released by activated monocytes. The apolipoprotein E and the tumor necrosis factor ß polymorphisms are risk factors for atherosclerosis. The aim of the study was to investigate whether the genetic variants of apolipoprotein E (APOE*E4) and tumor necrosis factor ß (TNFB*A329G) affect cytokine release after cardiopulmonary bypass.
METHODS: Thirty-eight patients underwent standard coronary artery bypass grafting procedures. Genotyping for APOE*E4 and TNFB*A329G was performed. Concentrations of interleukin 8 and tumor necrosis factor
were measured for 48 hours after surgery. Clinical data were collected prospectively.
RESULTS: Fourteen patients (37%) carried the combination non-APOE*E4/wild-type TNFB*A329, 12 patients (32%) showed non-APOE*E4/TNFB*A329G, 9 patients (24%) had APOE*E4/TNFB*A329G, and 3 patients (7%) had APOE*E4/wild-type TNFB*A329. Total amount of tumor necrosis factor
was significantly higher in patients carrying the combination APOE*E4/TNFB*A329 than in those carrying non-APOE*E4/wild-type TNFB*A329 (P < .0001). Clinical data were similar except for intubation time and amount of transfusion, which were significantly increased in patients with genetic polymorphisms (P = .022, P = .033).
CONCLUSION: Presence of TNFB*A329G polymorphism in addition to APOE*E4 variant is associated with significantly higher releases of interleukin 8 and tumor necrosis factor
, prolonged intubation, and increased transfusion relative to patients without genetic variants. Preoperative determination of APOE/TNFB genotypes in patients undergoing coronary artery bypass grafting may lead to additional perioperative measures to ameliorate systemic inflammatory response.
This article has been cited by other articles:
![]() |
M. L. James, P. M. Sullivan, C. D. Lascola, M. P. Vitek, and D. T. Laskowitz Pharmacogenomic Effects of Apolipoprotein E on Intracerebral Hemorrhage Stroke, February 1, 2009; 40(2): 632 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ak, S. Isbir, A. Tekeli, A. Ergen, N. Atalan, S. Dogan, A. Civelek, and S. Arsan Presence of lipoprotein lipase S447X stop codon affects the magnitude of interleukin 8 release after cardiac surgery with cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 477 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Grocott Genetic influences on cerebral outcome after cardiac surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 291 - 296. [Abstract] [PDF] |
||||
![]() |
H. Riha, J. A. Hubacek, R. Poledne, P. Kellovsky, A. Brezina, and J. Pirk IL-10 and TNF-beta gene polymorphisms have no major influence on lactate levels after cardiac surgery. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 54 - 58. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |